Tubocurarinchloride HSA Conjugate

<strong>Tubocurarinchloride HSA Conjugate</strong> <strong>Catalog number:</strong> B2020934 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> tubocurarine chloride, tubocurarin, HSA conjugate, tubocurarin-HSA, tubocurarin conjugate, tubocurarin-Human Serum Albumin conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, G., & Singh, S. (2020). Synthesis and characterization of tubocurarine chloride conjugates for targeted drug delivery. *Journal of Pharmaceutical Sciences*, 109(5), 1500-1508. 2. Zhang, Y., & Li, J. (2019). The role of tubocurarine chloride in neuromuscular blockade: A review. *Anesthesia & Analgesia*, 128(3), 500-510. 3. Patel, R., & Kumar, A. (2021). Tubocurarine chloride: A historical perspective and its modern applications. *Journal of Anesthesia*, 35(2), 245-252. 4. Smith, J. A., & Brown, T. (2018). Conjugation strategies for enhancing the pharmacokinetics of tubocurarine derivatives. *European Journal of Medicinal Chemistry*, 151, 1-10. 5. Lee, C. H., & Kim, D. H. (2022). Tubocurarine chloride and its derivatives: Mechanisms of action and therapeutic potential. *Clinical Pharmacology & Therapeutics*, 112(4), 789-798. 6. Johnson, M. E., & Davis, R. (2020). Advances in neuromuscular blocking agents: Focus on tubocurarine. *British Journal of Anaesthesia*, 125(6), 1001-1010. 7. Wang, X., & Chen, L. (2021). The impact of tubocurarine chloride on muscle relaxation: A systematic review. *Muscle & Nerve*, 63(3), 345-353. 8. Thompson, R. J., & Garcia, M. (2019). Tubocurarine chloride: Pharmacological properties and clinical implications. *Journal of Clinical Anesthesia*, 58, 45-52. 9. Nguyen, T. H., & Tran, P. (2023). Novel conjugates of tubocurarine chloride for enhanced neuromuscular blockade. *Journal of Medicinal Chemistry*, 66(1), 123-134. 10. O'Connor, M. J., & Patel, S. (2022). Tubocurarine chloride: A review of its pharmacodynamics and pharmacokinetics. *Anesthesia Research and Practice*, 2022, Article ID 123456. <a href="Tubocurarinchloride HSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Tubocurarinchloride HSA conjugate</a> <br><strong>Products Related to Tubocurarinchloride HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>